ストックスクリーナーアプリを入手
21.60
1.46%
-0.32
前日終値:
$21.92
開ける：
$21.6
24時間の取引高:
58,806
Relative Volume:
0.54
時価総額：
$312.68M
収益：
$1.80M
当期純損益:
$1.76B
株価収益率:
0.182
EPS:
118.674
ネットキャッシュフロー:
$-149.23M
1週間 パフォーマンス:
-6.41%
1か月 パフォーマンス:
+47.24%
6か月 パフォーマンス:
+59.06%
1年 パフォーマンス:
+48.25%
1日の値動き範囲:
$21.37
$22.24
1週間の範囲:
$21.37
$25.29
52週間の値動き範囲:
$10.80
$25.29
Inhibrx Biosciences Inc Stock (INBX) Company Profile
名前
Inhibrx Biosciences Inc
セクター
電話
(858) 795-4220
住所
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA
INBX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INBX
Inhibrx Biosciences Inc
|
21.60 | 317.31M | 1.80M | 1.76B | -149.23M | 118.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Inhibrx Biosciences Inc Stock (INBX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-23 | 開始されました | JMP Securities | Mkt Perform |
| 2024-01-23 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-03-16 | 開始されました | SMBC Nikko | Outperform |
| 2021-09-21 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2020-09-14 | 開始されました | Credit Suisse | Outperform |
| 2020-09-14 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Inhibrx Biosciences Inc (INBX) 最新ニュース
Tools to assess Inhibrx Biosciences Inc.’s risk profileGrowth Summary Based on Market Positioning - Newser
Risk adjusted return profile for Inhibrx Biosciences Inc. analyzedVolume Based Swing Signal Prediction Map - Newser
Does Inhibrx Biosciences Inc. qualify in momentum factor screeningHigh Probability Trade Plan with Indicators - Newser
Inhibrx Biosciences Inc. Stock Analysis and ForecastUnlock exclusive trading strategies for gains - jammulinksnews.com
What is the risk reward ratio of investing in Inhibrx Biosciences Inc. stockConsistent high-performance stocks - jammulinksnews.com
Is Inhibrx Biosciences Inc. stock overvalued or undervaluedAmplify your gains with low-risk picks - jammulinksnews.com
What makes Inhibrx Biosciences Inc. stock price move sharplyPredictive Short-Term Market Reversal Alerts - Newser
What are Inhibrx Biosciences Inc. company’s key revenue driversNavigate market shifts with confidence - jammulinksnews.com
Should I hold or sell Inhibrx Biosciences Inc. stock in 2025Robust investment performance - jammulinksnews.com
When is Inhibrx Biosciences Inc. stock expected to show significant growthCapitalize on market momentum for profits - jammulinksnews.com
What institutional investors are buying Inhibrx Biosciences Inc. stockGet alerts on high-potential market moves - jammulinksnews.com
Inhibrx Biosciences Inc. Company Revenue and Profit Trends: A Deep DiveFree Daily Volume Spike Trading Signals - Newser
Will Inhibrx Biosciences Inc. outperform the marketConservative Asset Allocation Risk Analysis - Newser
Has Inhibrx Biosciences Inc. Stock Ever Crashed Historical Volatility ReviewStrategy Builder for Growth Focused Traders - Newser
What’s the recovery path for long term holders of Inhibrx Biosciences Inc.Risk-Managed Trade Alerts for Consistency - Newser
Published on: 2025-08-01 16:27:04 - metal.it
Why Inhibrx Biosciences Inc. stock attracts strong analyst attentionShort Term Gain Strategy with AI Logic - Newser
Inhibrx Biosciences Inc. stock prediction for this weekQuick Profit Setup with Signal Forecast - Newser
What moving averages say about Inhibrx Biosciences Inc.Price Forecast Based on AI Analysis - Newser
Intrinsic Value of Inhibrx Biosciences Inc. Stock: Is It Undervalued or OvervaluedBuy Strategy with Smart Exit Timing - Newser
How Inhibrx Biosciences Inc. stock performs during market volatilityIn-Depth Stock Trading Volume Analysis - Newser
How does Inhibrx Biosciences Inc. compare to its industry peersFinancial News Tips To Watch Now - jammulinksnews.com
Sectors Driving Future Growth for Inhibrx Biosciences Inc. StockLong-Term Allocation Strategy Summary Breakdown - Newser
Reversal indicators forming on Inhibrx Biosciences Inc. stockEarly Entry Planner for Swing Candidates - Newser
New Product Launches: Will They Boost Inhibrx Biosciences Inc. Stock in 2025Real Trader Watchlist of Hot Stocks Released - metal.it
Is Inhibrx Biosciences Inc. Starting a New UptrendHigh Yield Stock Screening Results Explained - metal.it
Bollinger Bands Show Potential Breakout in Inhibrx Biosciences Inc.Oversold Recovery Opportunity Stocks Attract Buyers - metal.it
Inhibrx Biosciences Inc. Nearing Breakout Level After BounceInvestment Plan With Growth Optimization Finalized - metal.it
Inhibrx Biosciences Inc. Flashes Rebound Signal in Oversold ConditionAI Screening for Swing Trade Picks Finds Momentum - metal.it
Is Inhibrx Biosciences Inc. Forming a Consolidation BaseTechnical Stock Breakout Predictions Signal Entry Points - metal.it
Is Inhibrx Biosciences Inc. the Top Chart Pick This WeekHigh Accuracy Alerts for ROI Traders Detected - metal.it
Trend Reversal Possible in Inhibrx Biosciences Inc. Charts IndicateTechnical Stock Breakout Predictions Signal Entry Points - metal.it
How does Inhibrx Biosciences Inc. generate profit in a changing economyUnlock expert trading strategies for growth - jammulinksnews.com
Inhibrx Biosciences Advances HexAgon-HN Study for Head, Neck Cancer - Insider Monkey
How strong is Inhibrx Biosciences Inc. company’s balance sheetGet exclusive access to premium stock research - jammulinksnews.com
Is Inhibrx Biosciences Inc. a growth stock or a value stockGame-changing capital returns - jammulinksnews.com
Inhibrx Biosciences Inc. stock trendline breakdownDividend Strategy Summary With 10-Year Outlook - Newser
Inhibrx Biosciences Inc (INBX) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
0.15%
大文字化:
|
ボリューム (24 時間):